GlassScriptPhysician profile
James Cosgrove
NPI 1881631562
$5,805.95
in general payments reported to CMS, 2019-2025
25 companies · $38.99 in 2025
The $38.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $520 · 2020: $133 · 2021: $128 · 2022: $4,657 · 2023: $147 · 2024: $181 · 2025: $38.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,449.43 | 2021-2023 | Lo Loestrin Fe |
| Intuitive Surgical, INC. | $2,045.71 | 2022-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $247.20 | 2021-2024 | Truclear |
| Duchesnay USA Incorporated | $151.39 | 2019-2022 | |
| Ethicon US, LLC | $123.68 | 2021-2022 | |
| Exact Sciences Corporation | $115.51 | 2023-2025 | Cologuard Collection Kit |
| Lupin INC. | $82.62 | 2019 | |
| Covidien LP | $68.07 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.47 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $56.73 | 2019 | |
| Therapeuticsmd, INC. | $48.54 | 2019 | |
| Amgen INC. | $48.28 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $47.48 | 2019-2022 | |
| Allergan, INC. | $42.94 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.68 | 2023 | Gattex |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $29.31 | 2019 | |
| Dysis Medical, INC. | $27.96 | 2020 | |
| Smith+Nephew, INC. | $19.01 | 2025 | Grafix Pl, Stravix, Stravix Pl |
| Myovant Sciences INC. | $17.99 | 2021 | |
| Astellas Pharma US INC | $17.90 | 2021 | |
| Tactile Systems Technology INC | $17.61 | 2024 | Entre Plus, Flexitouch Plus |
| Boston Scientific Corporation | $16.20 | 2019 | |
| Pfizer INC. | $13.90 | 2019 | |
| Avion Pharmaceuticals | $13.44 | 2020 | |
| Evofem Biosciences, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cosgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.